Bill
Bill > SB48
OK SB48
OK SB48Schools; allowing self-administration of replacement pancreatic enzymes for certain treatment. Effective date. Emergency.
summary
Introduced
02/04/2019
02/04/2019
In Committee
04/09/2019
04/09/2019
Crossed Over
03/07/2019
03/07/2019
Passed
04/29/2019
04/29/2019
Dead
Signed/Enacted/Adopted
05/02/2019
05/02/2019
Introduced Session
2020 Regular Session
Bill Summary
An Act relating to schools; amending 70 O.S. 2011, Section 1-116.3, as last amended by Enrolled Senate Bill 381 of the 1st Session of the 57th Oklahoma Legislature, which relates to students self- administering certain medications; allowing the self- administration of replacement pancreatic enzymes for the treatment of cystic fibrosis; modifying certain definition; requiring renewal of certain permission; providing an effective date; and declaring an emergency. SUBJECT: Treatment of cystic fibrosis in schools
AI Summary
This bill amends an existing law to allow students with cystic fibrosis to self-administer replacement pancreatic enzymes at school, in addition to the existing provisions allowing students to self-administer asthma and anaphylaxis medications. The bill requires the school district to adopt a policy allowing such self-administration, with certain conditions such as parental authorization and a written statement from the student's physician. The bill also provides liability protections for the school district and its employees. The bill becomes effective on July 1, 2019 and declares an emergency.
Committee Categories
Education
Sponsors (3)
Last Action
Approved by Governor 05/02/2019 (on 05/02/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | http://www.oklegislature.gov/BillInfo.aspx?Bill=sb48&Session=2000 | 11/20/2019 |
Loading...